MAPT and Alzheimer disease: Indeed, C18-Cer levels in CSF were significantly associated with the presence of classical AD markers, such as Aβ42 and total tau, as well as inflammatory markers, such as S100 calcium-binding protein B (S100B) in the earlier stages of dementia [183].